Abrogation of Fas-Induced Fulminant Hepatic Failure in Mice by Hepatocyte Growth Factor
- 1 March 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 244 (3), 683-690
- https://doi.org/10.1006/bbrc.1998.8293
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 31 references indexed in Scilit:
- Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and RegenerationBiochemical and Biophysical Research Communications, 1997
- Apoptosis by Death FactorCell, 1997
- Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosisNature, 1996
- CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xLImmunity, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Serum hepatocyte growth factor levels in liver diseases: Clinical implicationsHepatology, 1995
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factorBiochemical and Biophysical Research Communications, 1989
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984